ÂÜÀòÂÒÂ×

Amit K. Sachdev is Chief Regulatory Officer at Vertex Pharmaceuticals, where he has served over the past decade in numerous executive leadership roles spanning the business as an executive officer and member of the Executive Committee. During this time, the company has experienced sevenfold growth and successfully developed and commercialized 4 novel breakthrough medicines for patients with serious liver disease and for patients with a life-threatening lung disease called cystic fibrosis.

Today, Vertex is one of the world’s leading global biotechnology companies with its headquarters in Boston, Massachusetts and London, England. Throughout the prior decade, Mr. Sachdev held various senior executive appointments in government both at the US FDA and in the US House of Representatives. He also practiced law first at the American Chemistry Council and at the law firm of Ropes and Gray.

Mr. Sachdev serves on several non-profit and philanthropic boards, including MassBIO, a biotechnology innovation association in Massachusetts, and Imagine and Answer, a charity group focused on supporting research into rare forms of low-grade pediatric brain cancer. In 2017, he joined the Board of Advisors for the Stanford Center for Longevity Studies.

Mr. Sachdev received a BS from Carnegie Mellon University and a JD from Emory University School of Law.